Published in N Engl J Med on July 17, 1980
Detection of antibodies to hepatitis C virus in U.S. blood donors. J Clin Microbiol (1991) 1.17
Detection of non-A, non-B hepatitis antigen by immunocytochemical staining. Proc Natl Acad Sci U S A (1984) 0.85
Detection and transmission in chimpanzees of hepatitis B virus-related agents formerly designated "non-A, non-B" hepatitis. Proc Natl Acad Sci U S A (1982) 0.85
Acute hepatic failure in children. Yale J Biol Med (1984) 0.84
A glycoprotein associated with the non-A, non-B hepatitis agent(s): isolation and immunoreactivity. Proc Natl Acad Sci U S A (1985) 0.75
Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis (2000) 6.05
Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med (2000) 5.27
Antibody to hepatitis-B-virus core in man. Lancet (1973) 4.24
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67
Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem (2000) 2.47
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem (2000) 2.30
Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med (1978) 2.30
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med (1978) 2.29
Inhibition by desferrioxamine of in-vitro replication of HIV-1. Lancet (1991) 2.05
Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. N Engl J Med (1974) 1.98
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med (1981) 1.96
Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med (1974) 1.92
Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis (2000) 1.87
Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics (1991) 1.86
Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet (1978) 1.82
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troops. Am J Epidemiol (2001) 1.71
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med (1987) 1.61
Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol (1982) 1.60
Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study. Lancet (1975) 1.59
Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis (1982) 1.59
Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis (1975) 1.55
Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst (1992) 1.51
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis (1976) 1.51
Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women? Hepatology (1984) 1.49
Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology (1989) 1.45
Plasma derivatives and viral hepatitis. Transfusion (1982) 1.40
Transmission of hepatitis B by immune serum globulin. Lancet (1979) 1.40
Did HIV and HTLV originate in Africa? JAMA (1990) 1.38
Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay. Gastroenterology (1977) 1.34
Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology (1985) 1.32
The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med (2001) 1.30
Polysaccharide in delayed hypersensitivity. I. Pneumococcal polysaccharide as inducer and elicitor of delayed reactivity in guinea pigs. J Exp Med (1970) 1.30
Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med (1984) 1.30
Hepatitis B core antigen: immunology and electron microscopy. J Virol (1974) 1.30
Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver (1999) 1.29
Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion (2000) 1.29
Hepatitis B and primary hepatocellular carcinoma in a European population. Lancet (1978) 1.27
Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus. J Infect Dis (1978) 1.26
Transmission of non-A, non-B hepatitis. Ann Intern Med (1977) 1.25
Effect of ethanol during hepatitis B virus infection in chimpanzees. J Med Virol (1978) 1.24
Immunoprophylaxis of viral hepatitis. Gastroenterology (1979) 1.21
The three viruses of non-A, non-B hepatitis. Lancet (1985) 1.18
Newly licensed hepatitis B vaccine. Known safety and unknown risks. JAMA (1983) 1.16
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med (1986) 1.14
Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee. Gastroenterology (1978) 1.13
Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med (1986) 1.12
Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet (1996) 1.12
A sequence in HpaI-P fragment of herpes simplex virus-1 DNA determines intraperitoneal virulence in mice. Virology (1986) 1.12
The natural history of hepatitis C-A quandary. Hepatology (1998) 1.11
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy. J Viral Hepat (2008) 1.11
Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol (1976) 1.11
Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol (1990) 1.10
Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst (1977) 1.10
Acute non-A, non-B hepatitis: specific ultrastructural alterations in endoplasmic reticulum of infected hepatocytes. Lancet (1979) 1.10
Alphafetoprotein levels of liver cancer patients and controls in a European population. Cancer (1980) 1.09
Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Infect Dis (1983) 1.08
VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr (1986) 1.07
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology (1977) 1.04
Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial. Aliment Pharmacol Ther (2010) 1.04
Viral hepatitis type B during pregnancy, the neonatal period, and infancy. J Pediatr (1977) 1.04
New findings in live, attenuated hepatitis A vaccine development. J Med Virol (1986) 1.04
Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs. J Immunol (1976) 1.03
Nine-year follow-up study of a plasma-derived hepatitis B vaccine in a rural African setting. J Med Virol (1993) 1.03
Human recombinant soluble CD4 therapy. Lancet (1990) 1.03
Effects of cyclophosphamide on hepatitis B virus infection and challenge in chimpanzees. J Infect Dis (1975) 1.03
Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis (1983) 1.02
A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice. Arch Virol (1983) 1.01
Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat (2002) 1.01
Humoral and cell-mediated immune responses to two hepatitis B virus antigens in guinea pigs. J Immunol (1974) 1.00
Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. J Med Virol (1985) 1.00
The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci (1979) 0.99
Significance of megamitochondria in alcoholic liver disease. Gastroenterology (1986) 0.99
Causes of increased plasma creatine kinase activity after surgery. Clin Chem (1974) 0.99
Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study. Am J Med Sci (1976) 0.99
Hepatotoxicity of analgesics and anti-inflammatory agents. Gastroenterol Clin North Am (1995) 0.98
Antibody to hepatitis B core antigen in blood donors with a history of hepatitis. Transfusion (1981) 0.98
Treatment of chronic active hepatitis. An analysis of three controlled trials. Gastroenterology (1977) 0.97
Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis. Ann Rheum Dis (1989) 0.97
Apparent potentiation of acetaminophen hepatotoxicity by alcohol. Ann Intern Med (1980) 0.96
Detection of e antigen during acute and chronic hepatitis B virus infections in chimpanzees. J Infect Dis (1977) 0.96
Summary of an international workshop on hepatitis B vaccines. J Infect Dis (1979) 0.96
Hepatitis C: a brief clinical overview. ILAR J (2001) 0.96
Simultaneous acute infections with hepatitis A and hepatitis B viruses in a chimpanzee. J Infect Dis (1979) 0.96